MG
IDXX icon

Mather Group’s Idexx Laboratories IDXX Stock Holding History

Mather Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$960K Buy
1,823
+159
+10% +$89.2K 0.01% 385
2026
Q1 		$935K Buy
1,664
+190
+13% +$122K 0.01% 346
2025
Q4 		$997K Buy
1,474
+25
+2% +$17K 0.01% 282
2025
Q3 		$926K Sell
1,449
-13
-0.9% -$7.89K 0.01% 292
2025
Q2 		$784K Buy
1,462
+702
+92% +$336K 0.01% 311
2025
Q1 		$319K Buy
760
+329
+76% +$143K ﹤0.01% 475
2024
Q4 		$178K Sell
431
-186
-30% -$81.6K ﹤0.01% 603
2024
Q3 		$312K Buy
617
+23
+4% +$11.2K ﹤0.01% 456
2024
Q2 		$321K Buy
594
+24
+4% +$12K ﹤0.01% 516
2024
Q1 		$316K Sell
570
-8
-1% -$4.37K 0.01% 430
2023
Q4 		$321K Sell
578
-102
-15% -$47.9K 0.01% 440
2023
Q3 		$297K Buy
680
+208
+44% +$104K 0.01% 442
2023
Q2 		$237K Buy
+472
New +$226K ﹤0.01% 512
2022
Q2 		– Sell
-389
Closed -$213K – 429
2022
Q1 		$213K Buy
+389
New +$205K ﹤0.01% 418

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Mather Group's IDXX Position: Q2 2026 in Review

Mather Group increased its Idexx Laboratories (IDXX) stake by 9.6% in Q2 2026, buying an estimated $89.2K and bringing the position to 1,823 shares worth $960K. The position accounts for 0.01% of the portfolio, ranked #385.

Mather Group first reported a position in IDXX in Q1 2022 and has held it in 14 quarters since. The position peaked at $997K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Mather Group held 1,823 shares of Idexx Laboratories worth $960K as of Q2 2026.
  • Mather Group bought 159 Idexx Laboratories shares in Q2 2026, an estimated $89.2K.
  • Idexx Laboratories made up 0.01% of Mather Group's portfolio in Q2 2026, its #385 holding.
  • Mather Group first reported a position in Idexx Laboratories in Q1 2022 and has held it in 14 quarters since.
  • Mather Group's Idexx Laboratories position peaked at $997K in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.